- Our Doctors
- Dr Susan Lupton
Dr Susan Lupton
Dr Susan Lupton
Susan
Lupton
MBChB, CCT, MRCP, FRCR
Clinical Oncologist
Languages spoken
English
Expert in
Breast cancer
Overview
Centres
Birmingham
Birmingham
GenesisCare Birmingham, Little Aston Hall Drive, Sutton Coldfield, West Midlands, B74 3BF, England, UK
52.60208, -1.87412
/uk/our-centres/birmingham
West Midlands
Specialises in
Treatments
Intensity modulated radiotherapy (IMRT)
Partial breast irradiation
Dr Susan Lupton is a clinical oncologist with a special clinical interest in breast cancer.
She has held a substantive post at University Hospitals Coventry and Warwickshire since 2013, specialising in the oncological management of breast cancer.
She works across two hospitals, delivering chemotherapy and radiotherapy at University Hospital Coventry and Warwickshire for patients from George Eliot Hospital in Nuneaton, as well as for patients locally within Coventry and Warwickshire.
She has an interest in researching new techniques to improve treatments for her patients, including the use of deep inspiration breath hold to reduce late toxicities from radiotherapy.
Career positions
Current position(s)
- Clinical Oncologist
Education
Universities
- University Hospitals Coventry
- University Warwickshire
Residencies
- George Elliot Hospitals in Nuneaton
Expertise and interests
Expertise
- Breast cancer
Professional association
- Royal College of Physicians (RCP)
- Royal College of Radiologists (RCR)
- British Medical Association (BMA)
- British Oncology Association (BOA)
- European Society for Radiotherapy and Oncology (ESTRO)
Accomplishments
Publications
- Comparison of CT-volumed supraclavicular fossa radiotherapy planning and conventional simulator-planned defined by bony landmarks for early breast cancer (May 2016)
- Optimising Limb Immobilisation for Sarcoma Radiotherapy (June 2015)
- 735 poster A COMPARISON OF TECHNIQUES: CONVENTIONAL SIMULATOR VERSES CT-VOLUMED SUPRACLAVICULAR FOSSA RADIOTHERAPY FOR ADJUVANT BREAST CANCER (May 2011)
- Outcome of T1N0M0 Squamous Cell Carcinoma of the Larynx Treated with Short-course Radiotherapy to a Total Dose of 50 Gy in 16 Fractions: the Birmingham Experience (May 2009)
- Use of Imatinib Mesylate in Gastrointestinal Stromal Tumours: Pan-Birmingham Cancer Network Experience (June 2008)